News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,606 Results
Type
Article (61639)
Company Profile (640)
Press Release (683327)
Multimedia
Podcasts (94)
Webinars (14)
Section
Business (208350)
Career Advice (3095)
Deals (36807)
Drug Delivery (126)
Drug Development (84054)
Employer Resources (182)
FDA (17459)
Job Trends (15964)
News (357466)
Policy (35738)
Tag
Academia (2979)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (54203)
ALS (104)
Alzheimer's disease (1496)
Antibody-drug conjugate (ADC) (159)
Approvals (17418)
Artificial intelligence (302)
Autoimmune disease (28)
Automation (16)
Bankruptcy (378)
Best Places to Work (12449)
BIOSECURE Act (21)
Biosimilars (119)
Biotechnology (437)
Bladder cancer (84)
Brain cancer (30)
Breast cancer (311)
Cancer (2460)
Cardiovascular disease (202)
Career advice (2604)
Career pathing (34)
CAR-T (175)
Cell therapy (479)
Cervical cancer (22)
Clinical research (67868)
Collaboration (931)
Company closure (2)
Compensation (518)
Complete response letters (29)
COVID-19 (2843)
CRISPR (50)
C-suite (270)
Cystic fibrosis (109)
Data (2355)
Decentralized trials (2)
Denatured (33)
Depression (55)
Diabetes (298)
Diagnostics (6865)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (133)
Drug pricing (129)
Drug shortages (32)
Duchenne muscular dystrophy (102)
Earnings (82440)
Editorial (44)
Employer branding (23)
Employer resources (157)
Events (112835)
Executive appointments (781)
FDA (18879)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (817)
Gene editing (124)
Generative AI (26)
Gene therapy (351)
GLP-1 (836)
Government (4993)
Grass and pollen (6)
Guidances (150)
Healthcare (20522)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (142)
Indications (30)
Infectious disease (3005)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (102)
Interviews (578)
IPO (16935)
IRA (49)
Job creations (3993)
Job search strategy (2158)
Kidney cancer (11)
Labor market (42)
Layoffs (538)
Leadership (24)
Legal (8527)
Liver cancer (82)
Lung cancer (348)
Lymphoma (160)
Machine learning (9)
Management (62)
Manufacturing (361)
MASH (79)
Medical device (14424)
Medtech (14429)
Mergers & acquisitions (20449)
Metabolic disorders (791)
Multiple sclerosis (89)
NASH (22)
Neurodegenerative disease (113)
Neuropsychiatric disorders (33)
Neuroscience (2101)
NextGen: Class of 2025 (7405)
Non-profit (5032)
Now hiring (39)
Obesity (427)
Opinion (268)
Ovarian cancer (82)
Pain (102)
Pancreatic cancer (91)
Parkinson's disease (162)
Partnered (23)
Patents (257)
Patient recruitment (119)
Peanut (51)
People (59527)
Pharmaceutical (132)
Pharmacy benefit managers (22)
Phase I (21171)
Phase II (29777)
Phase III (22500)
Pipeline (1393)
Policy (175)
Postmarket research (2637)
Preclinical (9309)
Press Release (71)
Prostate cancer (114)
Psychedelics (34)
Radiopharmaceuticals (268)
Rare diseases (432)
Real estate (6636)
Recruiting (72)
Regulatory (24565)
Reports (45)
Research institute (2633)
Resumes & cover letters (495)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (79)
Series A (141)
Series B (93)
Service/supplier (27)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (159)
Sponsored (34)
Startups (3933)
State (2)
Stomach cancer (15)
Supply chain (76)
Tariffs (53)
The Weekly (60)
Vaccines (811)
Venture capitalists (41)
Weight loss (298)
Women's health (35)
Worklife (20)
Date
Today (174)
Last 7 days (976)
Last 30 days (3178)
Last 365 days (34268)
2025 (12189)
2024 (37101)
2023 (41855)
2022 (53252)
2021 (57890)
2020 (56952)
2019 (50555)
2018 (38456)
2017 (35309)
2016 (34854)
2015 (40421)
2014 (32931)
2013 (28662)
2012 (30875)
2011 (31157)
2010 (28832)
Location
Africa (983)
Alabama (61)
Alaska (7)
Arizona (228)
Arkansas (14)
Asia (46202)
Australia (7760)
California (6502)
Canada (2094)
China (571)
Colorado (283)
Connecticut (298)
Delaware (164)
Europe (101026)
Florida (958)
Georgia (226)
Hawaii (1)
Idaho (60)
Illinois (608)
India (30)
Indiana (341)
Iowa (12)
Japan (176)
Kansas (112)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (960)
Massachusetts (4884)
Michigan (248)
Minnesota (427)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (67)
New Hampshire (69)
New Jersey (1823)
New Mexico (31)
New York (1833)
North Carolina (1137)
North Dakota (9)
Northern California (2776)
Ohio (224)
Oklahoma (15)
Oregon (46)
Pennsylvania (1422)
Puerto Rico (14)
Rhode Island (35)
South America (1361)
South Carolina (26)
South Dakota (1)
Southern California (2426)
Tennessee (107)
Texas (979)
United States (24774)
Utah (199)
Virginia (174)
Washington D.C. (70)
Washington State (597)
West Virginia (3)
Wisconsin (70)
745,606 Results for "alpha pro tech ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period and year ended December 31, 2023.
March 13, 2024
·
18 min read
Business
Alpha Pro Tech, Ltd. Announces Third Quarter 2023 Financial Results
Alpha Pro Tech, Ltd. announced financial results for the three and nine month period ended September 30, 2023.
November 7, 2023
·
18 min read
Business
Alpha Pro Tech, Ltd. Announces Second Quarter 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three and six month periods ended June 30, 2023.
August 8, 2023
·
20 min read
Business
Alpha Pro Tech, Ltd. Announces First Quarter 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period ended March 31, 2023.
May 9, 2023
·
16 min read
Business
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2022 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period and year ended December 31, 2022.
March 16, 2023
·
19 min read
Business
Alpha Pro Tech, Ltd. Announces Third Quarter 2022 Financial Results
Alpha Pro Tech, Ltd. announced financial results for the three and nine month periods ended September 30, 2022.
November 7, 2022
·
22 min read
Drug Development
Hi-Tech Pharmaceuticals Phase Two Launch of Revolutionary PRO IGF-1® -- The First Successful Production of Actual IGF-1 In A Dietary Supplement
Hi-Tech Pharmaceuticals moves into its Phase two launch of PRO IGF-1®.
June 26, 2024
·
3 min read
Business
Alpha Pro Tech, Ltd. Announces First Quarter 2022 Financial Results
Alpha Pro Tech, Ltd. announced financial results for the three month period ended March 31, 2022.
May 10, 2022
·
15 min read
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Press Releases
Alpha Tau to Participate in March Investor Conferences
February 27, 2025
·
1 min read
1 of 74,561
Next
